Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

NCT01786265 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma
Recurrent Prostate Carcinoma

Interventions

DRUG: Abiraterone Acetate
DRUG: Bicalutamide
DRUG: Degarelix
DRUG: Flutamide
DRUG: Goserelin Acetate
DRUG: Leuprolide Acetate
DRUG: Nilutamide
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center